ARTICLE | Discovery & Translation
BioCentury’s roundup of translational news
By Danielle Golovin, Biopharma Analyst
June 16, 2023 11:34 PM UTC
A group led by Cardea Bio Inc. co-founders Brett Goldsmith and Kiana Aran reported in Advanced Materials Technologies a graphene-based biosensor that detects antigen and RNA of SARS-CoV-2, including the Omicron variant, without the need for amplification. “The reported platform can be quickly adapted for multi-omics and multiplexed diagnosis of continuously evolving biothreats and global pandemics,” said the authors.
Paragraf Ltd., a mass producer of graphene electronics, acquired Cardea in May…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- EVM Finance. Unified Interface for Decentralized Finance. Access Here.
- Quantum Media Group. IR/PR Amplified. Access Here.
- PlatoAiStream. Web3 Data Intelligence. Knowledge Amplified. Access Here.
- Source: https://www.biocentury.com/article/648325/cardea-s-covid-biosensor-plus-gut-microbes-in-alzheimer-s-risk-and-more
